Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 14, 2021
Mogrify and the MRC Laboratory of Molecular Biology (LMB) have announced an exploratory research collaboration.
read more
NewAge is one-hundred percent employee owned.
read more
Baxter BioPharma Solutions has entered into an agreement to provide sterile manufacturing services for NVX-CoV2373, Novavax’ COVID-19 recombinant nanoparticle vaccine candidate.
read more
Biond Biologics has entered into an exclusive worldwide license agreement with Sanofi for the development and commercialization of BND-22.
read more
Wednesday, January 20, 2021
Charles River Laboratories has entered into a strategic partnership with JADE, a provider of end-to-end quality management services for the biopharmaceutical industry.
read more
Wednesday, January 20, 2021
LSNE Contract Manufacturing expands vial filling and lyophilization capacity with the addition of a new automated aseptic fill line.
read more
Wednesday, January 20, 2021
Gritstone has obtained a nonexclusive license to Genevant’s LNP technology to develop and commercialize SAM vaccines against SARS-CoV-2.
read more
Wednesday, January 20, 2021
Recipharm and Enzymatica have signed a broadened contract for the manufacture of ColdZyme.
read more
Wednesday, January 20, 2021
Raremark has appointed Nicki Grundy as Chief Financial Officer to support the accelerated levels of growth the company is experiencing.
read more
Wednesday, January 20, 2021
Cobra Biologics, the gene therapy division of the Cognate BioServices’ group, has announced a multi-phase augmentation of its plasmid DNA services as a continuation of its Gene Therapy services’ expansion project for viral vectors and plasmid DNA.
read more
Thursday, January 21, 2021
Intravacc announced a candidate polyvalent inactivated coxsackievirus B vaccine it developed and manufactured for Provention Bio has entered into a first in human Phase I clinical study.
read more
Thursday, January 21, 2021
Oxford BioTherapeutics has selected a second bispecific program that will combine an anti-PD-L1 antibody with OBT’s immuno-oncology candidate.
read more
Thursday, January 21, 2021
Metrion Biosciences and LifeArc have announced a 12-month extension of their neuroscience drug discovery collaboration.
read more
Thursday, January 21, 2021
Quanticate has named Lee Patterson as the company's Chief Operating Officer (COO).
read more
Civica Rx has announced plans to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia.
read more